MCM
FOLD

McKinley Capital Management’s Amicus Therapeutics FOLD Stock Holding History

McKinley Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-400,650
Closed -$9.25M – 185
2020
Q4 		$9.25M Sell
400,650
-1,143
-0.3% -$23.4K 0.66% 52
2020
Q3 		$5.67M Sell
401,793
-90
-0% -$1.31K 0.44% 65
2020
Q2 		$6.06M Sell
401,883
-100
-0% -$1.22K 0.41% 59
2020
Q1 		$3.71M Sell
401,983
-2,146
-0.5% -$20.4K 0.3% 74
2019
Q4 		$3.94M Buy
+404,129
New +$3.7M 0.26% 90
2019
Q2 		– Sell
-1,706
Closed -$23K – 238
2019
Q1 		$23K Hold
1,706
– – ﹤0.01% 267
2018
Q4 		$16K Sell
1,706
-1,845
-52% -$20.3K ﹤0.01% 283
2018
Q3 		$43K Sell
3,551
-306
-8% -$4.28K ﹤0.01% 284
2018
Q2 		$60K Sell
3,857
-336
-8% -$5.08K ﹤0.01% 292
2018
Q1 		$63K Sell
4,193
-117,110
-97% -$1.78M ﹤0.01% 293
2017
Q4 		$1.75M Buy
121,303
+84
+0.1% +$1.15K 0.09% 169
2017
Q3 		$1.83M Buy
+121,219
New +$1.6M 0.07% 168

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McKinley Capital Management's FOLD Position: Q1 2021 in Review

McKinley Capital Management sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 400,650 shares — an estimated $9.25M sold.

McKinley Capital Management first reported a position in FOLD in Q3 2017 and held it in 12 quarters. The position peaked at $9.25M in Q4 2020. 259 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • McKinley Capital Management reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • McKinley Capital Management sold 400,650 Amicus Therapeutics shares in Q1 2021, an estimated $9.25M.
  • McKinley Capital Management first reported a position in Amicus Therapeutics in Q3 2017 and held it in 12 quarters.
  • McKinley Capital Management's Amicus Therapeutics position peaked at $9.25M in Q4 2020.
  • 259 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on McKinley Capital Management's 13F filing for Q1 2021, filed 21 Apr 2021.